Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
Targeting cells in motion: migrating toward improved therapies.
B-Cell Targeting Agents in the Treatment of Multiple Sclerosis.
Glucosamine modulates T cell differentiation through downregulating N-linked glycosylation of CD25.
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
Charcot-Marie-Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies.
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deﬁcits in multiple sclerosis.
Longitudinal change detection: Inference on the diffusion tensor along white matter pathways.
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.
Physical and social environment and the risk of multiple sclerosis.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.

Pages